Data / Drug companies / Bupivacaine hydrochloride
Bupivacaine hydrochloride: 23 companies and 103 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bupivacaine hydrochloride is listed in the FDA National Drug Code Directory by 23 companies, with 103 products in commercial distribution. 85 of the products (82.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on June 24, 2026.
The request: Get every company that lists bupivacaine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 23
- Products
- 103
- Generic (ANDA) products
- 85 (82.5%)
- Application numbers
- 21
- Routes
- Perineural, Epidural, Intracaudal, Infiltration, Retrobulbar
- Brand names
- Marcaine, Sensorcaine MPF, Bupivacaine HCl, Sensorcaine MPF, Sensorcaine, Sensorcaine, Marvona Suik, Marvona-25 Suik
- openFDA record search
- api.fda.gov
Companies that list bupivacaine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Hospira, Inc. | 12 | injection, solution | Generic drugs (ANDA) | August 28, 2025 |
| Fresenius Kabi USA, LLC | 11 | injection, solution | New drug applications (NDA) | November 19, 2010 |
| Eugia US LLC | 8 | injection, solution | Generic drugs (ANDA) | May 13, 2016 |
| Hikma Pharmaceuticals USA Inc. | 8 | injection, solution | Generic drugs (ANDA) | February 11, 2021 |
| NorthStar RxLLC | 8 | injection, solution | Generic drugs (ANDA) | December 16, 2024 |
| Onesource Specialty Pharma Limited | 8 | injection, solution | Generic drugs (ANDA) | January 29, 2026 |
| Xellia Pharmaceuticals USA LLC | 8 | injection, solution | Generic drugs (ANDA) | August 1, 2023 |
| Henry Schein, Inc. | 7 | injection, solution | New drug applications (NDA) | June 24, 2026 |
| Anthea Pharma Private Limited | 5 | injection, solution | Generic drugs (ANDA) | April 22, 2026 |
| Asclemed USA, Inc. | 5 | injection, solution | Generic drugs (ANDA) | February 11, 2021 |
| Camber Pharmaceuticals, Inc. | 3 | injection, solution | Generic drugs (ANDA) | March 27, 2024 |
| Medical Purchasing Solutions, LLC | 3 | injection, solution | Generic drugs (ANDA) | May 13, 2016 |
| Sportpharm LLC | 3 | injection, solution | Generic drugs (ANDA) | May 13, 2016 |
| Fosun Pharma USA Inc. | 2 | injection, solution | Generic drugs (ANDA) | February 6, 2026 |
| Meitheal Pharmaceuticals Inc. | 2 | injection, solution | Generic drugs (ANDA) | June 23, 2023 |
| ProPharma Distribution | 2 | injection, solution | Generic drugs (ANDA) | November 22, 2005 |
| Somerset Therapeutics, LLC | 2 | injection, solution | Generic drugs (ANDA) | November 27, 2023 |
| A-S Medication Solutions | 1 | injection, solution | Generic drugs (ANDA) | May 13, 2016 |
| Asclemed USA Inc. | 1 | injection, solution | Other unapproved drugs | January 24, 2026 |
| Brookfield Pharmaceuticals, LLC. | 1 | injection | Generic drugs (ANDA) | October 31, 2022 |
| Cardinal Health 107, LLC | 1 | injection, solution | Generic drugs (ANDA) | January 6, 2010 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, solution | Generic drugs (ANDA) | October 16, 2019 |
| Huons Co., Ltd. | 1 | injection | Generic drugs (ANDA) | December 30, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 101 | 98.1% |
| Injection | 2 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 85 | 82.5% |
| New drug applications (NDA) | 16 | 15.5% |
| Other unapproved drugs | 2 | 1.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Amide Local Anesthetic | 103 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.